Resverlogix Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Selling, General & Admin	1.98	1.8	3.02	7.21	11.39	8.28
Research & Development	2.92	2.81	2.16	4.23	4.55	6.29
Operating Expenses	4.9	4.6	5.18	11.43	15.94	14.57
Operating Income	-4.9	-4.6	-5.18	-11.43	-15.94	-14.57
Interest Expense	-0.97	-0.09	-0.01	-1.64	-0.83	-1.95
Currency Exchange Gain (Loss)	0.01	0.05	-0.02	0.03	-0.08	-0.4
Other Non Operating Income (Expenses)	-3.16	-2.47	-1.08	3.76	4.86	7.63
EBT Excluding Unusual Items	-9.02	-7.1	-6.28	-9.28	-11.99	-9.29
Asset Writedown	-	-	-1.03	-1.28	-	-0.11
Other Unusual Items	1.94	-0.52	-9.41	6.97	-12.77	11.89
Pretax Income	-7.08	-7.62	-16.73	-3.59	-24.76	2.5
Income Tax Expense	0.01	0.01	0.02	0.02	0.01	0.03
Net Income	-7.09	-7.64	-16.74	-3.61	-24.77	2.46
Net Income to Common	-7.09	-7.64	-16.74	-3.61	-24.77	2.46
Net Income Growth	-	-	-	-	-	-97.91%
Shares Outstanding (Basic)	283	277	270	254	240	220
Shares Outstanding (Diluted)	283	277	270	254	240	232
Shares Change (YoY)	3.22%	2.46%	6.11%	6.07%	3.46%	4.71%
EPS (Basic)	-0.03	-0.03	-0.06	-0.01	-0.10	0.01
EPS (Diluted)	-0.03	-0.03	-0.06	-0.01	-0.10	0.01
EPS Growth	-	-	-	-	-	-97.93%
Free Cash Flow	-3.05	-3.89	-2.51	-3.63	-8.02	-4.4
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.01	-0.03	-0.02
EBITDA	-4.49	-4.25	-4.82	-10.97	-15.52	-14.2
D&A For EBITDA	0.41	0.35	0.36	0.47	0.42	0.37
EBIT	-4.9	-4.6	-5.18	-11.43	-15.94	-14.57
Effective Tax Rate	-	-	-	-	-	1.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.